Effect of Feldenkrais Method in Enhancing Postural Control for Patients with Diabetic Polyneuropathy
FeM
Effect of the Feldenkrais Method on Enhancing Postural Control in Patients with Diabetic Polyneuropathy
1 other identifier
interventional
24
1 country
1
Brief Summary
Background: Postural Control is a major complication of polyneuropathy, affecting patients suffering from diabetes mellitus. Purpose: To examine the effect of the Feldenkrais Method on dynamic balance, limits of stability and fear of falling in adults aged 45 to 60 years with diabetic polyneuropathy in the short and mid-term. Methods: A single-blinded, parallel, multicentric randomized control trial was conducted in two health centers. Adults aged 45 to 60 years with diabetic polyneuropathy and a history of falls or dynamic balance dysfunction were recruited from hospital databases and randomly assigned to either the study or control group. The study group received 16 sessions of Feldenkrais-based sensorimotor training. Both groups received diabetic foot care instructions and traditional balance exercises. Outcomes were measured at 3 and 6-month follow-up intervals. Dynamic balance was assessed using the Timed Up and Go (TUG) Test, limits of stability using Biodex and fear of falling with the Falls Efficacy Scale (FES).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Mar 2025
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2025
CompletedStudy Start
First participant enrolled
March 30, 2025
CompletedFirst Posted
Study publicly available on registry
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedApril 1, 2025
December 1, 2024
1 month
February 5, 2025
March 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Dynamic Balance
Assessed using the Timed Up and Go Test, which measures the time taken to stand from a seated position, walk three meters, turn around, walk back, and sit down.
From enrollment to the end of treatment at 12 weeks
Postural Control
Evaluated using the Biodex Balance System, which measures limits of stability and sway index
From enrollment to the end of treatment at 12 weeks
Fear of Falling
Assessed using the Falls Efficacy Scale, a self-reported measure of confidence in performing daily activities without falling.
From enrollment to the end of treatment at 12 weeks
Study Arms (2)
The Feldenkrais-based intervention
EXPERIMENTALthis group recieve The Feldenkrais-based intervention consisted of guided awareness exercises
a conventional balance training program
ACTIVE COMPARATORThe control group participated in a conventional balance training program consisting of static and dynamic balance exercises, gait training, and strength-building activities, matched for session frequency and duration
Interventions
The Feldenkrais-based intervention consisted of guided awareness exercises aimed at improving movement patterns, proprioception, and postural control. Sessions were conducted twice weekly for 12 weeks, with each session lasting approximately 45 minutes
a conventional balance training program consisting of static and dynamic balance exercises, gait training, and strength-building activities, matched for session frequency and duration
Eligibility Criteria
You may qualify if:
- Individuals must have a diagnosis of Diabetic Polyneuropathy (DPN), confirmed by clinical examination and electrophysiological testing.
- Participants must have stable glycemic control for at least three months prior to enrollment.
- Individuals must be able to walk independently, with or without the use of an assistive device.
You may not qualify if:
- Individuals with severe visual or vestibular impairments are excluded from participation.
- Participants with significant musculoskeletal disorders affecting gait are not eligible.
- Individuals with severe cardiovascular or respiratory conditions are excluded.
- Participants with cognitive impairments that prevent active participation are not eligible.
- Individuals currently engaged in structured physical therapy or balance training programs are excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo University
Cairo, Cairo Governorate, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physiotherapist
Study Record Dates
First Submitted
February 5, 2025
First Posted
April 1, 2025
Study Start
March 30, 2025
Primary Completion
April 30, 2025
Study Completion
June 30, 2025
Last Updated
April 1, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share